Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for combined therapy.

E Frei

    Cancer
    |July 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Adjuvant chemotherapy significantly improves disease-free survival by targeting micrometastatic cancer cells. Combined modality treatments show promising results for breast cancer and osteogenic sarcoma patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen.

    Parasitology·2007
    Same author

    Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.

    General physiology and biophysics·2007
    Same author

    Aminopterin-human serum albumin conjugate (AP-HSA): uptake and cytotoxic effects in tumor cell lines.

    International journal of clinical pharmacology and therapeutics·2002
    Same author

    Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.

    Anti-cancer drug design·2002
    Same author

    The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
    Same author

    Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.

    General physiology and biophysics·2002
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Cancer Metastasis Research

    Background:

    • Micrometastatic disease at diagnosis is a primary driver of cancer treatment failure.
    • Understanding the mechanisms, biology, and biochemistry of tumor metastasis is crucial for developing effective therapies.

    Purpose of the Study:

    • To present the evolution of clinical trials incorporating adjuvant chemotherapy for combined modality treatment.
    • To evaluate the impact of these treatments on disease-free survival in specific cancer types.

    Main Methods:

    • Clinical trials involving adjuvant chemotherapy combined with local control (surgery/radiotherapy) and systemic treatment (chemotherapy/immunotherapy).
    • Focus on studies conducted over the past five years in breast cancer and osteogenic sarcoma patients.

    Main Results:

    Related Experiment Videos

    • Adjuvant chemotherapy has led to improved disease-free survival in both breast cancer and osteogenic sarcoma.
    • Short-term results of multi-disciplinary treatment strategies are promising.

    Conclusions:

    • Combined modality treatment, including adjuvant chemotherapy, offers a promising approach to eradicate microscopic metastases.
    • Further long-term follow-up is necessary to fully ascertain the impact on patient outcomes across various diseases.